Triple Negative Breast Cancer and PARP Inhibitors

In this video, Dr. Robert Carlson, MD, talks about triple negative breast cancer and PARP inhibitors. Dr. Carlson is a Professor of Medicine at at the Stanford Comprehensive Cancer Center. In part, he talks about the PARP pathway and how PARP inhibitors allow a different approach to DNA cell repair and cancer treatment. Here’s the video:

Triple Negative Breast Cancer and PARP Inhibitors

 

Leave a Comment

Your email address will not be published. Required fields are marked *